Explore Ametris' educational resources to gain a deeper understanding of Digital Health Technologies in clinical trials.
Popular Searches:
Featured Resource
Optimizing Wearable Adherence in a Phase 3 Oncology Trial Through Real-Time Data Workflows
Ametris partnered with Johnson & Johnson Innovative Medicine to improve wearable adherence in the global Phase 3 LIBERTAS trial for a metastatic castration-sensitive prostate cancer (mCSPC) therapy. In this study, actigraphy devices were used for more than 12 months to continuously measure sleep quality and physical activity as objective proxies for hot flash burden.
No resources match your search. Try adjusting your filters.
Schedule a Meeting with Our Science Team
Ready to accelerate your DHT strategy? Our experts can help. Schedule a meeting with a member of our Science Team to receive personalized guidance on maximizing the benefits of DHTs throughout the clinical development lifecycle.